Consun Pharmaceutical Group Ltd. (HK:1681) has released an update.
Consun Pharmaceutical Group Ltd. reports a solid financial performance in the first half of 2024, with a revenue increase of 13.3% and a profit jump of 14.9% compared to the same period in 2023. The company also saw a rise in both basic and diluted earnings per share by over 12%, alongside declaring an interim dividend of HKD0.3 per share.
For further insights into HK:1681 stock, check out TipRanks’ Stock Analysis page.
